Skip to content

Clinical trials

Hypoparathyroidism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20063
20084
20093
20102
20114
20121
20133
20145
20152
20165
20177
20186
20196
20205
20219
20227
20234
20248
20258
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Recruiting22
Unknown status10
Terminated6
Active, not recruiting5
Suspended3
Not yet recruiting3
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire11
University of Aarhus5
Aristotle University Of Thessaloniki4
Ascendis Pharma A/S4
Amorphical Ltd.3
Ascendis Pharma Bone Diseases A/S3
Calcilytix Therapeutics, Inc., a BridgeBio company3
Entera Bio Ltd.3
Fujian Medical University3
MBX Biosciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism111
Hypocalcemia24
Thyroid Neoplasms9
Parathyroid Diseases8
Thyroid Diseases8
Endocrine System Diseases7
Hypercalciuria6
Hyperparathyroidism6
Pseudohypoparathyroidism6
DiGeorge Syndrome5

Trials

Showing 26 to 50 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.